These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14555497)

  • 1. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging drugs for head and neck cancer.
    Rhee JC; Khuri FR; Shin DM
    Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.
    Bernier J
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting important pathways in head and neck cancer: from the bench to the clinic.
    Santos ES; Perez C; Donald CE; Raez LE
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of squamous cell carcinoma of the head and neck.
    Kim J; Shin DM
    Histol Histopathol; 1997 Jan; 12(1):205-18. PubMed ID: 9046056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular approaches to the staging of head and neck carcinomas (review).
    Gasparotto D; Maestro R
    Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials.
    Rewari AN; Haffty BG; Wilson LD; Son YH; Joe JK; Ross DA; Papac RJ; Sasaki CT; Fischer JJ
    Cancer J; 2006; 12(2):123-9. PubMed ID: 16630403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR; Cullen K
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
    Lee KD; Lee HH; Joo HB; Lee HS; Yu TH; Chang HK; Jeon CH; Park JW
    Anticancer Res; 2006; 26(2B):1513-8. PubMed ID: 16619566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is gene expression profiling of head and neck cancers ready for the clinic?
    Ziober AF; D'Alessandro L; Ziober BL
    Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
    Dasgupta S; Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Valentino J; Chatterjee SK
    Oral Oncol; 2006 Mar; 42(3):306-16. PubMed ID: 16321566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers of radiation effectiveness in head and neck squamous cell carcinoma.
    Koch W; Sidransky D
    Semin Radiat Oncol; 2004 Apr; 14(2):130-8. PubMed ID: 15095259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.